Hyperlipidemia remains one of the primary risk factors in the development of atherosclerotic cardiovascular disease, underscoring the need for effective and individualized management strategies. With recent advancements in therapeutic approaches, healthcare professionals now have a broader spectrum of options for addressing persistent hyperlipidemia in high-risk patients. Yet, navigating the complex landscape of statin and nonstatin treatments can be challenging, especially when addressing barriers to timely treatment escalation. Tune in to hear expert faculty provide insights into the latest guideline recommendations, clinical evidence, and real-world applications in hyperlipidemia management. Emphasizing advanced lipid-lowering therapies beyond statins, this program equips participants to apply practical, multidisciplinary approaches that facilitate access to essential therapies and optimize patient outcomes. This activity is delivered in partnership with The American Society for Preventive Cardiology (ASPC).
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/beyond-statin-therapy-evidence-based-strategies-advanced-therapeutic
- Start Date: 2024-12-18 06:00:00
- End Date: 2024-12-18 06:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Novartis Corporation Pharmaceuticals - Amount: 129750.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all